Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan.

Toxins (Basel) · 2026 · PMC12945157 · PMID 41745775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The PEGR score showed a trend toward a reduction (improvement) from the first injection baseline in patient-assessed blepharospasm symptoms throughout the study period ( Table S5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.